37. Generalised pustular psoriasis
58 clinical trials,   50 drugs   (DrugBank: 18 drugs),   17 drug target genes,   96 drug target pathways

Searched query = "Generalised pustular psoriasis", "Pustular psoriasis", "Herpetic impetigo", "Generalization of acrodermatitis continua", "Generalization of dermatitis continua of the extremities"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03051217
(ClinicalTrials.gov)
February 21, 20179/2/2017A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic PsoriasisPhase 2/3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic PsoriasisModerate to Severe Psoriasis;Generalized Pustular Psoriasis and Erythrodermic PsoriasisOther: Placebo;Drug: Certolizumab PegolUCB Biopharma S.P.R.L.NULLCompleted20 YearsN/AAll127Phase 2;Phase 3Japan